Precision oncology: Diagnosis and treatment of TRK fusion-positive GI cancers

December 06, 2023 00:18:01
Precision oncology: Diagnosis and treatment of TRK fusion-positive GI cancers
COR2ED - Oncology Medical Conversation
Precision oncology: Diagnosis and treatment of TRK fusion-positive GI cancers

Dec 06 2023 | 00:18:01

/

Show Notes

In this podcast, PO CONNECT members Prof Frédérique Penault-Llorca (University of Clermont-Ferrand, France) and Prof Andrea Sartore-Bianchi (Niguarda Cancer Centre, Milan, Italy) provide both a pathologist and medical oncologist perspective about the detection and treatment of TRK fusion-positive GI cancers, with a particular focus on colorectal cancer.

Penault-Llorca and Sartore-Bianchi start by explaining TRK fusion biology, the role as oncogenic drivers and briefly describe the two approved TRK inhibitors. They then discuss the challenges of finding patients harboring these fusions, referring to how enrichment strategies and predictors can aid identification in patients with GI cancers. Finally, they discuss key efficacy and safety data for larotrectinib and entrectinib, as well as mentioning second-generation products in development to tackle mechanisms of resistance.

Other Episodes

Episode

December 06, 2023 00:20:49
Episode Cover

RCC: Treating advanced RCC - The role of VEGFR-TKIs alone or in combination therapy

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Prof. Georg Hutterer, a Urologist from the Medical University of...

Listen

Episode

December 06, 2023 00:24:55
Episode Cover

Precision oncology: An introduction to molecular testing

This podcast episode provides an introduction to molecular testing in the diagnosis and treatment of cancer.  Prof. David Hong from MD Anderson Cancer Center,...

Listen

Episode

December 06, 2023 00:21:09
Episode Cover

Colorectal cancer: Treatment sequencing in advanced mCRC

This podcast episode discusses treatment sequencing in advanced metastatic colorectal cancer (mCRC) patients, third line and beyond.  Dr Shubham Pant from MD Anderson Cancer...

Listen